✦ LIBER ✦

PP-8-6 Paclitaxel (P) versus doxorublcin (D) as first line chemotherapy (CT) in advanced breast cancer (ABC): A randomized trial with crossover of the EORTC-IDBBC in collaboration with EORTC-ECSG

✍ Scribed by P. Bruning; M.J. Piccart; J. Klijn; T. Gamucci; Z. Kusenda; J.A. Roy; A. Van Vreckem; R. Paridaens; IDBBC

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

645 - Taxol (T) versus doxorubicin (D) a

✍ R. Paridaens; P. Bruning; J. Klljn; T. Gamucci; L. Biganzoli; A. Van Vreckem; G. 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 280 KB

First results of a randomized phase III

✍ R Paridaens; P Therasse; L Dirix; L Beex; M.J Piccart; D Cameron; T Cufer; K Roo 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 172 KB